MétaCan
Menu
Back to cohort
Record W2618654433 · doi:10.1093/ndt/gfx153.sp587

SP587OMEGA-3 PUFA SUPPLEMENTATION TO PREVENT ARTERIOVENOUS FISTULA AND GRAFT FAILURE: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

2017· article· en· W2618654433 on OpenAlexaff
Andrea K. Viecelli, Ashley Irish, Carmel M. Hawley, Charmaine E. Lok, David W. Johnson, Elaine M. Pascoe, Giovanni Strippoli, Kevan R. Polkinghorne, Trevor A. Mori, Suetonia C. Palmer

Bibliographic record

VenueNephrology Dialysis Transplantation · 2017
Typearticle
Languageen
FieldHealth Professions
TopicCentral Venous Catheters and Hemodialysis
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsMedicineMeta-analysisArteriovenous fistulaRandomized controlled trialIntensive care medicineSurgerySystematic reviewMEDLINEInternal medicine

Abstract

fetched live from OpenAlex

INTRODUCTION AND AIMS: Arteriovenous (AV) access failure occurs frequently in people on haemodialysis (HD) and is associated with increased morbidity, mortality and healthcare costs. Use of omega-3 polyunsaturated fatty acids (omega-3 PUFA) may improve vascular access outcomes via pleiotropic effects on access maturation and function, but may be limited by bleeding complications. We evaluated the benefits and harms of omega-3 PUFA supplementation to prevent dialysis AV access complications in people requiring chronic HD. METHODS: Systematic review with meta-analysis of randomised controlled trials evaluating the efficacy and safety of omega-3 PUFA supplementation on AV access outcomes in adults requiring chronic HD. Trials were identified by highly-sensitive searches in Cochrane CENTRAL, MEDLINE, and Embase through 20 January 2017. Pre-specified outcomes were primary patency loss, bleeding, dialysis suitability failure (defined as an access that despite radiological or surgical interventions, cannot be used successfully for dialysis), access abandonment, interventions to maintain patency or assist maturation, gastrointestinal side effects, all-cause and cardiovascular mortality, hospitalisation, and treatment adherence. Treatment effects were summarised as relative risks (RR) with 95% confidence intervals (CI). Confidence in the evidence was assessed using GRADE. RESULTS: Five eligible trials comparing omega-3 PUFA supplementation with placebo were included in the meta-analysis (833 people) with an average follow-up time of 11.8 months. One trial (567 people) included people with a fistula and four included people with a graft. In moderate quality evidence, omega-3 PUFA supplementation reduced the risk of primary patency loss (3 trials, 761 people, RR 0.81, CI 0.68-0.98) but low quality evidence showed uncertain effects on access suitability for dialysis in a single trial (536 people, RR 0.95, CI 0.73-1.23), access abandonment (2 trials, 732 people, RR 0.78, CI 0.59-1.03), and need for interventions (2 trials, 732 people, RR 0.82, CI 0.64-1.04; Figure 1). Overall, risks of bleeding (4 trials, 794 people, RR 1.40, CI 0.78-2.49), gastrointestinal side effects (4 trials, 816 people, RR 1.22, CI 0.64-2.34), and all-cause mortality (4 trials, 799 people, RR 0.98, CI 0.51-1.86) were uncertain with low quality evidence. There was no evidence of heterogeneity in risk estimates based on access type (AV fistula or graft). Risk of bias was low overall. SP587 Figure

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.011
metaresearch head score (Gemma)0.027
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.022
Threshold uncertainty score0.058

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0110.027
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0220.038
Bibliometrics0.0060.006
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.064
GPT teacher head0.382
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueNephrology Dialysis TransplantationSame topicCentral Venous Catheters and HemodialysisFrench-language works237,207